Gene · 6392
Papers2,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes. | Endocr Oncol | 2022 | 37435466 | PubTator, text mining | PubMed |
| Paragangliomas of the head and neck: a contemporary review. | Endocr Oncol | 2022 | 37435464 | PubTator, text mining | PubMed |
| Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal? | Endocr Oncol | 2022 | 37435457 | PubTator, text mining | PubMed |
| Molecular docking analysis of melamine with nuclear factor erythroid 2-related factor 2 and succinate dehydrogenase. | Bioinformation | 2022 | 37323555 | PubTator, text mining | PubMed |
| Ga-68 DOTATATE PET/CT in the Evaluation of Paragangliomas and Other Indeterminate Lesions in the Head and Neck. | Indian J Nucl Med | 2022 | 36817195 | PubTator, text mining | PubMed |
| Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines. | Cell Genom | 2022 | 36778047 | PubTator, text mining | PubMed |
| Case Report: A rare case of primary paraganglioma of the gallbladder with a literature review. | Front Oncol | 2022 | 36776377 | PubTator, text mining | PubMed |
| Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma. | Front Endocrinol (Lausanne) | 2022 | 36760809 | PubTator, text mining | PubMed |
| Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms. | Front Oncol | 2022 | 36733351 | PubTator, text mining | PubMed |
| Simultaneous bilateral laparoscopic cortical-sparing adrenalectomy for bilateral pheochromocytomas in multiple endocrine neoplasia type 2. | Front Surg | 2022 | 36704524 | PubTator, text mining | PubMed |
| Dimorphic glioblastoma with glial and epithelioid phenotypes: Clonal evolution and immune selection. | Front Neurol | 2022 | 36703629 | PubTator, text mining | PubMed |
| Hypoxia signaling pathway: A central mediator in endocrine tumors. | Front Endocrinol (Lausanne) | 2022 | 36699028 | PubTator, text mining | PubMed |
| [Case of clinically "aggressive" course of primary hyperparathyroidism, algorithm of differential diagnosis]. | Probl Endokrinol (Mosk) | 2022 | 36689712 | PubTator, text mining | PubMed |
| Inefficient Batteries in Heart Failure: Metabolic Bottlenecks Disrupting the Mitochondrial Ecosystem. | JACC Basic Transl Sci | 2022 | 36687274 | PubTator, text mining | PubMed |
| Application of the shear wave elastography in the assessment of carotid body tumors: A preliminary study. | Front Oncol | 2022 | 36686815 | PubTator, text mining | PubMed |
| SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas. | Front Genet | 2022 | 36685941 | PubTator, text mining | PubMed |
| Multi-Omics Approach Reveals Redox Homeostasis Reprogramming in Early-Stage Clear Cell Renal Cell Carcinoma. | Antioxidants (Basel) | 2022 | 36670943 | PubTator, text mining | PubMed |
| The SDHD:p.H102R Variant Is Frequent in Russian Patients with Head and Neck Paragangliomas and Associated with Loss of 11p15.5 Region and Hypermethylation of H19-DMR. | Int J Mol Sci | 2022 | 36614070 | PubTator, text mining | PubMed |
| GISTs with NTRK Gene Fusions: A Clinicopathological, Immunophenotypic, and Molecular Study. | Cancers (Basel) | 2022 | 36612101 | PubTator, text mining | PubMed |
| The Effect of Oxidative Phosphorylation on Cancer Drug Resistance. | Cancers (Basel) | 2022 | 36612059 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6392/papers?page=21